PubRank

Yu-Xiao Yang

Author PubWeight™ 31.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol 2003 2.20
2 Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med 2008 1.99
3 Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst 2014 1.50
4 Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci 2007 1.50
5 Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry 2015 1.43
6 Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome. Pancreas 2013 1.41
7 Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology 2012 1.16
8 Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med 2010 1.11
9 No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol 2011 1.05
10 Do diabetes drugs modify the risk of pancreatic cancer? Gastroenterology 2009 1.04
11 Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas 2013 1.03
12 Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf 2012 0.99
13 Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005 0.98
14 Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer 2012 0.96
15 Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology 2009 0.93
16 Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf 2008 0.88
17 Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev 2012 0.88
18 Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol 2007 0.85
19 Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf 2009 0.84
20 Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause 2012 0.84
21 Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol 2007 0.84
22 Digoxin use and the risk for colorectal cancer. Pharmacoepidemiol Drug Saf 2014 0.82
23 Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 2015 0.81
24 Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol 2005 0.79
25 Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology 2005 0.79
26 Barrett's esophagus in 2008: an update. Keio J Med 2008 0.79
27 Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study. Eur J Gastroenterol Hepatol 2015 0.79
28 Changes of the HSD17B10 gene expression levels in ulcerative colitis. Inflamm Bowel Dis 2013 0.78
29 Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. J Clin Gastroenterol 2010 0.77
30 Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol 2014 0.76
31 Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas 2014 0.75
32 Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients. Inflamm Bowel Dis 2016 0.75
33 Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol 2007 0.75
34 A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis. Inflamm Bowel Dis 2017 0.75
35 Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors. Clin Nucl Med 2015 0.75
36 Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas 2017 0.75